MiniMed Group (MMED) stock

Insulin pumps , market cap $5.4B

Insulin pumps and glucose monitors

Worth $5.4B

$18.17

-5.83%

As of 3:59 PM ET, delayed 15+ min · Live for Pro members

Quality Score

Below Average

In its industry

#64of 85

Medical Devices

Checks firing

3of 14

Trending down

From its high

-25.6%

under its best since listing

MMED's Quality Score fell 4 points on Thu, Nov 5, to 1.

New listing, trading since Mar 6, 2026. 170 trading days so far, so 1 of the 14 chart checks waits for more history.

See MMED's 14 chart checksSee it live, free until Saturday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on MMED

Key facts on MMED
Holding it back	A $309M loss wider than $206M a year earlier
Latest filing	8-K, Oct 16 Reported a change in control and reported a change of officers or directors

1 more reason behind MMED's 1, free with an account →2 more reasons behind MMED's 1, for Pro members.

MMED in the news

TodayOn a down day.

What's next

Tue Dec 1: Evercore ISI 9th Annual HealthCONx…Investor conference · date confirmed.

3 more dates ahead: conferences and the IPO anniversary, for Pro members.

MMED catalysts

Coming up

After its last 2 reports it closed +13.3% on average, higher 2 of 2 times.

Why MMED scores 1

Below Averagefor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means

+3Chart checks 3 of 14 firing right now, one point each
+1Run-up 55% over 6 months

Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
Dilution subtractsNew shares over the year: -1 at 10% more, -2 at 25% more.
Volatility subtractsA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.

No effect today: Long-term trend, Size, Growth, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on MMED and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 3:59 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Alert me when MMED's Quality Score turns up

See it live, free until Saturday morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

The same page for Pro members, on AMD
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on MMED and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

MMED has 3 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on MMED, and all 14 on every stock.Get in free →

MMED RSI today: 43.8, below its 50-day average

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

RSI 1443.8
Above 30, below 50.
MACD (12, 26, 9)Above signal
Crossed above its signal line 8 sessions ago.
50-day average$20.08
The price is 9.5% below it.
200-day average
Not enough history yet.
50/200 cross
Not enough history yet.
ADX 1425.8
25 or more, with +DI below -DI.
Support$16.55
Swing low from Oct 14, 8.9% below the price.
Resistance$20.88
Swing high from Aug 13, 14.9% above the price.
High since listing$24.43
From Sep 2, 34.5% above the price.
Low since listing$10.65
From May 15, 41.4% below the price.
Chart patternTriangle
Lines over the Oct 9 and Oct 29 highs and under the Oct 14 and Oct 30 lows.
Bollinger Bands (20, 2)Inside
The bands run from $17.01 to $19.84.
Volume0.6x
Against its 20-day average, for the time of day.

The deep dive on MMED

What it does and how it makes money4 findingsFor Pro members4 findings on what MMED does and how it makes money, for Pro members
Where it stands3 findingsIts share count rose 11.2% in the year to Jul 31, 2026.Weighted shares, the quarter to Jul 31, 2026
What changed in its filings3 findings"On March 10, 2026, the Tribunal dismissed EOFlow’s claims against Medtronic without prejudice." (10-Q for the quarter to Jul 31, 2026)SEC filing · Sep 8, 2026
Who holds and trades it2 findingsFor Pro members2 findings on who holds and trades MMED, for Pro members
Against its closest peers1 peerNet income over four quarters: MMED -$309M, DXCM $1.00B.

10 more findings on MMED, each with its source, for Pro membersGet in free →

How MMED ranks in Medical Devices

MMED is #64 of 85 by Quality Score.

How MMED ranks in Medical Devices
1	EWEdwards Lifesciences	9/14	20
2	LIVNLivaNova	7/14	19
3	DXCMDexCom	5/14	19
	MDTMedtronic		Open for its score
	MDXGMiMedx		Open for its score
	MMM3M		Open for its score
	MMSIMerit Medical Systems		Open for its score
64	MMEDMiniMed	3/14	1

Net income over four quarters: MMED -$309M, DXCM $1.00B.

When does MMED report earnings, and what happens after?

Reports Tue Nov 24, before the open (in 19 days). Confirmed.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What MMED reported on Sep 1, 2026

The quarter

The figures are not read from the release yet.

“International net sales of $603 million grew 18.1% as reported and 16.9% organic, driven by Simplera™ capacity expansion and the launch of the Instinct sensor, made by Abbott”

The filing on EDGAR

Where the sales came from

MMED's results filing gives no sales by line in a table we read.

The outlook

No outlook figures read from this release.

In the company's words

“U.S. New Pumps Sold (NPS) grew over 20% year over year, driven by MiniMed Flex™ and new sensor launches”

From its results filing (SEC filing · Sep 1)

1 more sentence, for Pro members.

The numbers

Market value: $5.4B; today

No analyst estimates on Breakaway: every figure here is filed.

The whole report on MMED: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.Get in free →

+15.9%+10.7%

Jun 3Sep 1

Reported	When	Gap	Reaction	5 sessions
Sep 1, 2026Before open	Before open	+0.7%	+10.7%	+15.1%
Jun 3, 2026Before open	Before open	+3.4%	+15.9%	+22.9%

MMED closed higher after 2 of its last 2 reports.

MMED sales and profit by year

Sales and profit by year

Sales grew every year from 2024 to 2026, to $3.1B. It lost money in each of the three years.

MMED share count over time

Shares: 11.2% more than a year ago (to Jul 31).

Shares of MMED outstanding, as filed
Shares outstanding	As of
281.3M	Sep 3, 2026
280.8M	Jun 19, 2026
280.8M	Apr 11, 2026

Offerings, shelves, and splits of MMED, from its filings
From its filings	Filed
Raised $560M in a sale of shares, about 10% of its market value	Mar 6, 2026

MMED's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Que DallaraChief Executive Officer
Chad SpoonerEVP, Chief Financial Officer
Ali DianatyEVP Ch. Prod. & Tech Officer
Courtney Nelson WillsSVP, Gen. Counsel, Corp. Sec.
Gillian ChandrasenaSVP, Chief HR Officer
John GyurciVP, Chief Accounting Officer
Sheila A. DentonSVP, Gen. Counsel & Corp. Sec.
Amy BrickerDirector

6 more officers and directors file at MMED. Each page above names the rest.

See insider trades by person

About MiniMed Group

While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.

2,800 employeesNorthridge, CAminimed.com

Listed on Nasdaq on Mar 5, 2026, and is 9.2% below its $20 offer price now. Its IPO filing and first days

What MiniMed Group says it competes with

“The diabetes medical device industry is highly competitive, with companies constantly innovating and developing new products, technologies, and treatment approaches.”

From its annual report, SEC filing · Jun 29, 2026

2 more sentences, what it says it does, and its sales by region, for Pro membersGet in free →

MMED's score card

MiniMed Group (MMED): Quality Score 1, Below Average, #64 of 85 in Medical Devices, with its price, on Breakaway — The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

What would turn MMED's score around: 6 things
4 more filings explained, a plain line each
Real-⁠time prices, no delay

See MMED's 14 chart checks

See it live, free until Saturday morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Nov 5, 2026: MMED's Quality Score is 1 (Below Average), #64 of 85 in Medical Devices.

Is MMED a good stock to buy? What its Quality Score says

MMED scores 1 today, which Breakaway calls Below Average. It is #64 of 85 in Medical Devices by Quality Score, with 3 of 14 chart checks firing. Shares: 11.2% more than a year ago (to Jul 31). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is MMED's Quality Score?

MMED scores 1 today, which Breakaway calls Below Average (0 to 5). That is #64 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind MMED's 1.

When does MMED report earnings?

Reports Tue Nov 24, before the open, a date the company confirmed. MMED closed higher after 2 of its last 2 reports. Past behavior, not a forecast.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.